Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for vaccines has been rising globally, with the COVID-19 pandemic being the primary driver. Jordan has not been an exception, with the Other Vaccines market in the country experiencing significant growth.
Customer preferences: Jordan has a high vaccination rate, with a majority of the population seeking vaccination against infectious diseases. This trend has been driven by the country's robust healthcare system, which has been successful in promoting vaccination awareness and availability. Additionally, the government has been offering free vaccinations for children, which has led to a high vaccination rate among the younger population.
Trends in the market: The Other Vaccines market in Jordan has been growing steadily, driven by the increasing prevalence of infectious diseases. The market has seen a rise in demand for vaccines against diseases such as meningitis, hepatitis, and influenza. Additionally, the COVID-19 pandemic has accelerated the growth of the market, with the government and private healthcare providers offering the vaccine to the population.
Local special circumstances: Jordan is a developing country with a high population density, which makes it vulnerable to infectious diseases. The country has a high number of refugees and displaced persons, which increases the risk of disease transmission. Therefore, the government has been proactive in promoting vaccination programs to prevent the spread of infectious diseases.
Underlying macroeconomic factors: Jordan has a robust healthcare system, which has been successful in promoting vaccination awareness and availability. The government has been investing in the healthcare sector, which has led to the development of modern healthcare facilities. Additionally, the country has a stable political environment, which has attracted foreign investment, leading to the growth of the healthcare sector. The COVID-19 pandemic has also led to increased government spending on healthcare, leading to the growth of the Other Vaccines market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
